UK Pharma Decries Govt's Latest No-Deal Brexit Planning
The provision of “express” freight capacity for medicines that need to be delivered urgently is among the latest proposals from the UK government to help cope with supply disruptions in the event of a no-deal Brexit. But the biopharmaceutical industry says some of the proposals are too short notice and will place additional burdens on companies.
You may also be interested in...
Ferry and other transport operators are to bring thousands of heavy goods vehicles a week to the UK carrying life-saving medicines and other supplies if the UK leaves the EU without a deal. However, the ferries will not use the standard cross-Channel ports, which are expected to become heavily congested in a no-deal scenario.
The UK has a new prime minister in Boris Johnson, who is likely to surround himself with strongly pro-Brexit ministers. The life sciences industry will need to continue lobbying for its interests to be protected in the event of a no-deal exit.
What is a medicines shortage? The answer may seem obvious, but the fact that European regulators have only now come up with a commonly agreed definition suggests otherwise.